American Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.

Press releases published on September 8, 2026

Sep. 8, 2026

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)

Indeterminate GlobeNewswire

Sep. 8, 2026

Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

Indeterminate GlobeNewswire

Sep. 8, 2026

Rani Therapeutics to Participate in Upcoming September Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

AirNexis Therapeutics Announces that AN01, a Dual PDE3/4 Inhibitor Dry Powder Inhaler (DPI) Met its Primary Endpoint in a Phase 2b COPD Study (HSK39004-T1-202) Conducted in China by AirNexis' partner Haisco Pharmaceutical Group

Indeterminate GlobeNewswire

Sep. 8, 2026

Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations

Indeterminate GlobeNewswire

Sep. 8, 2026

Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

FTC Solar Begins Shipments on 330 MW Fraser Coast Project in Australia

Indeterminate GlobeNewswire

Sep. 8, 2026

Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

Indeterminate GlobeNewswire

Sep. 8, 2026

BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema

Indeterminate GlobeNewswire

Sep. 8, 2026

SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Windward Bio announces positive Phase 2 results of WIN378 in asthma demonstrating significant improvements in lung function and airway inflammation with twice-yearly dosing, and initiates Phase 3

Indeterminate GlobeNewswire

Sep. 8, 2026

SimPure Back-to-School Sale: Plug-and-Use Water Filtration Designed for Student Life

Indeterminate GlobeNewswire

Sep. 8, 2026

Dynamic Creatures Emerges from Stealth to Launch New Category of Mobile, Interactive Character Robots for Hospitality and Entertainment

Indeterminate GlobeNewswire

Sep. 8, 2026

Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) at Upcoming Medical Meetings

Indeterminate GlobeNewswire

Sep. 8, 2026

Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results

Indeterminate GlobeNewswire

Sep. 8, 2026

CervoMed to Participate in September Investor Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

BioVie Announces Update to Parkinson’s Phase 3 Development Program

Indeterminate GlobeNewswire

Sep. 8, 2026

Domestic Metals Commences Drill Program at Smart Creek Project, Montana

Indeterminate GlobeNewswire

Sep. 8, 2026

Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board

Indeterminate GlobeNewswire